Geoff Muckle was born in 1977 in Johannesburg, South Africa. Following vocational studies in theology and psychology in Cape Town, he moved to England where he began a sales and marketing career in the pharmaceutical industry. Geoff climbed the commercial ladder in pharmaceuticals, gaining experience and expertise in the oncology sector across multiple management roles including leading Roche’s personalised oncology account management strategy across the pharma, diagnostics and R&D organisations. Having grown a passion for personalised medicine, he joined Champions Oncology in 2014 where alongside driving contract translational research across Europe, he successfully led the commercialisation of two personalised oncology solutions in the UK: the Champions TumourGraft, an in vivo drug-sensitivity testing platform, and the Caris Molecular Profiling test, a multi-platform molecular profiling technology. Geoff became the CEO of Imagen Therapeutics in 2018, focusing the company on developing it’s predictRx test, and implementing a clinical validation and commercialisation strategy.